Press release BioEclipse Initiates Enrollment in Phase 1 Dose-Escalation Clinical Trial for CRX100 at HonorHealth Research Institute
cardiovascular COVID leaves Scottsdale triathlete with heart rhythm irregularities, long-haul symptoms